Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tiberghien

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Transplantation|September 1, 1991
Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatmentP Tiberghien, E Racadot, B Lioure, et al.
Presse Medicale (Paris, France : 1983)|February 6, 1988
[Prolonged remission of Burkitt's lymphoma stage IV secondary to Hodgkin's disease]J Y Cahn, M Flesch, A Rozenbaum, et al.
Journal of Hematotherapy|June 11, 1998
Retroviral-mediated marker gene transfer in hematopoiesis-supportive marrow stromal cellsC E Bulabois, V Yerly-Motta, B T Mortensen, et al.
Human Gene Therapy|February 11, 1998
Retrovirus-mediated transfer of the herpes simplex type I thymidine kinase gene in alloreactive T lymphocytesE Contassot, C Ferrand, J M Certoux, et al.
Blood|April 15, 1994
Interleukin-2 treatment in lymphoma: a phase II multicenter studyC Gisselbrecht, D Maraninchi, J L Pico, et al.
Blood|April 21, 2001
Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantationV Lapierre, N Oubouzar, A Aupérin, et al.
Leukemia & Lymphoma|November 1, 1993
Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patientsM Delain, J Y Cahn, E Racadot, et al.
Transplantation Proceedings|February 1, 1991
Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantationP Herve, P Bordigoni, J Y Cahn, et al.
Transplantation|November 15, 1995
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III studyJ Y Cahn, P Bordigoni, P Tiberghien, et al.
Bone Marrow Transplantation|January 1, 1991
Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 studyD Blaise, A M Stoppa, D Olive, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Transplantation|September 1, 1991
Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatmentP Tiberghien, E Racadot, B Lioure, et al.
Presse Medicale (Paris, France : 1983)|February 6, 1988
[Prolonged remission of Burkitt's lymphoma stage IV secondary to Hodgkin's disease]J Y Cahn, M Flesch, A Rozenbaum, et al.
Journal of Hematotherapy|June 11, 1998
Retroviral-mediated marker gene transfer in hematopoiesis-supportive marrow stromal cellsC E Bulabois, V Yerly-Motta, B T Mortensen, et al.
Human Gene Therapy|February 11, 1998
Retrovirus-mediated transfer of the herpes simplex type I thymidine kinase gene in alloreactive T lymphocytesE Contassot, C Ferrand, J M Certoux, et al.
Blood|April 15, 1994
Interleukin-2 treatment in lymphoma: a phase II multicenter studyC Gisselbrecht, D Maraninchi, J L Pico, et al.
Blood|April 21, 2001
Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantationV Lapierre, N Oubouzar, A Aupérin, et al.
Leukemia & Lymphoma|November 1, 1993
Graft failure after T cell depleted HLA identical allogeneic bone marrow transplantation: risk factors in leukemic patientsM Delain, J Y Cahn, E Racadot, et al.
Transplantation Proceedings|February 1, 1991
Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantationP Herve, P Bordigoni, J Y Cahn, et al.
Transplantation|November 15, 1995
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III studyJ Y Cahn, P Bordigoni, P Tiberghien, et al.
Bone Marrow Transplantation|January 1, 1991
Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 studyD Blaise, A M Stoppa, D Olive, et al.
Pageof 15